Literature DB >> 1418702

B-cell activation.

S V Desiderio1.   

Abstract

Extraordinary progress has been made in refining our understanding of the B-cell antigen receptor complex, the role of protein-tyrosine phosphorylation as the key intermediary in immunoglobulin signal transduction, and in identifying candidate effectors of immunoglobulin-mediated signaling. In addition, the properties of a new group of G proteins may rekindle interest in older observations implicating such molecules as important in B-cell activation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1418702     DOI: 10.1016/0952-7915(92)90073-n

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  6 in total

Review 1.  Surface engineering for lymphocyte programming.

Authors:  Elana Ben-Akiva; Randall A Meyer; David R Wilson; Jordan J Green
Journal:  Adv Drug Deliv Rev       Date:  2017-05-10       Impact factor: 15.470

Review 2.  Polymeric micro- and nanoparticles for immune modulation.

Authors:  Elana Ben-Akiva; Savannah Est Witte; Randall A Meyer; Kelly R Rhodes; Jordan J Green
Journal:  Biomater Sci       Date:  2018-12-18       Impact factor: 6.843

3.  Requirement of phospholipase C-gamma 2 activation in surface immunoglobulin M-induced B cell apoptosis.

Authors:  M Takata; Y Homma; T Kurosaki
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

4.  Connections between signal transduction components and cellular responses initiated by antigen receptor on B lymphocytes.

Authors:  R H Scheuermann; J W Uhr
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

5.  Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled Ca2+ mobilization through distinct pathways.

Authors:  M Takata; H Sabe; A Hata; T Inazu; Y Homma; T Nukada; H Yamamura; T Kurosaki
Journal:  EMBO J       Date:  1994-03-15       Impact factor: 11.598

6.  Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling.

Authors:  T Kurosaki; M Takata; Y Yamanashi; T Inazu; T Taniguchi; T Yamamoto; H Yamamura
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.